Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel

Agostino Consoli, Leszek Czupryniak, Rui Duarte, Gyorgy Jermendy, Alexandra Kautzky-Willer, Chantal Mathieu, Miguel Melo, Ofri Mosenzon, Frank Nobels, Nikolaos Papanas, Gabriela Roman, Oliver Schnell, Alexis Sotiropoulos, Coen D. A. Stehouwer, Cees J. Tack, Vincent Woo, Gian Paolo Fadini*, Itamar Raz

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)1705-1713
Number of pages9
JournalDiabetes Obesity & Metabolism
Volume22
Issue number10
DOIs
Publication statusPublished - Oct 2020

Keywords

  • antidiabetic drug
  • sulphonylureas
  • ALL-CAUSE MORTALITY
  • CARDIOVASCULAR EVENTS
  • DPP-4 INHIBITORS
  • HEART-FAILURE
  • RISK
  • METFORMIN
  • METAANALYSIS
  • ASSOCIATION
  • COMBINATION
  • DRUGS

Cite this